A study examining donor-recipient pairs decades after hematopoietic cell transplantation finds no significant accelerated ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has had no related adverse events to date.

The following is a summary of “Association between early anti-cytomegalovirus therapy and the incidence of chronic ...

Patients with relapsed or refractory MDS may experience improved overall survival with , depending on certain prognostic ...

The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), ...

4 Hematopoietic stem cells within cord blood are responsible ... 5 Being a match to a leukemia patient who may have an ineffective bone marrow means providing a stem cell transplant to rectify their ...

StemCyte Inc., a wholly owned subsidiary of StemCyte International Ltd., announced today that the U.S. Food and Drug ...

T cells and allogeneic hematopoietic stem cell transplantation. Dr Simonetta's clinical work is mainly focused on Chimeric ...

The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.

Omeros ( OMER, Financials) announced progress toward resubmitting its biologics license application for narsoplimab, its ...

The Gift of Life club at the University of Minnesota provides students with resources to donate bone marrow and stem cells. ...

Opens in a new tab or window While high-dose chemotherapy and autologous hematopoietic cell transplantation ... suggesting ...